Tag Archives: Versant Ventures

December, 2016

12 December
Bayer and Versant Ventures Team up to Launch Stem Cell Therapy Company BlueRock Therapeutics with $225 Million Financing

LEVERKUSEN, Germany and BOSTON and NEW YORK and TORONTO and KYOTO, Japan, Dec. 12, 2016 /PRNewswire/ — Bayer AG and Versant Ventures today announced the launch of BlueRock Therapeutics, a next-generation regenerative medicine company that plans to develop best-in-class induced pluripotent stem cell (iPSC) therapies to cure a range of …
Share

29 April
Celgene Inks Cancer Deals with Agios Pharmaceuticals and Northern Biologics

Celgene is enhancing its oncology pipeline, striking separate cancer-focused deals with Agios Pharmaceuticals and startup Northern Biologics. Agios announced it is expanding its partnership with cancer metabolism partner Celgene. The companies have entered into a new joint worldwide development and profit share collaboration for AG-881, a small molecule that has …
Share